✦ LIBER ✦

Sa1445 A Novel Use of a Second Generation Photosensitizer Agent Combined With Gemcitabine for Pancreatic Cancer Therapy: In Vitro and In Vivo Results

✍ Scribed by Sun, Gang; Anderson, Marlys; Gorospe, Emmanuel C.; Timmer, Margriet R.; Leggett, Cadman L.; Uno, Kaname; Lutzke, Lori S.; Levy, Michael J.; Wang, Kenneth K.

Book ID: 122296913
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 350 KB
Volume: 77
Category: Article
ISSN: 1097-6779
DOI: 10.1016/j.gie.2013.03.496

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined Chemoradiation Therapy With Gem

Combined Chemoradiation Therapy With Gemcitabine and Cisplatinum for Organ Preservation in Muscle-invasive Bladder Cancer: Long-term Results of a Phase I Trial

✍ Riou, O.; Culine, S.; Rebillard, X.; Thezenas, S.; Faix, A.; Segui, B.; Pouessel 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 59 KB

547 Improvements in survival and clinica

547 Improvements in survival and clinical benefit with the use of gemcitabine (GEM) as first-line therapy for advanced pancreatic cancer: A randomized trial

✍ M. Moore 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 318 KB

Combined Chemoradiation Therapy With Twi

Combined Chemoradiation Therapy With Twice-Weekly Gemcitabine and Cisplatin for Organ Preservation in Muscle-Invasive Bladder Cancer: Long-Term Results of a Phase 1 Trial

✍ Azria, David; Riou, Olivier; Rebillard, Xavier; Thezenas, Simon; Thuret, Rodolph 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 338 KB

PD-147 A phase I study of a second gener

PD-147 A phase I study of a second generation antisenseoligonucleotide to clusterin (OGX-011) in combination with gemcitabine and cisplatin as first-line treatment for patients with advanced non-small cell lung cancer (NSCLC): Preliminary results

✍ Laskin, J.; Chi, K.; Melosky, B.; Sill, K.; Hao, D.; Canil, C.; Gleave, M.; Murr 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 129 KB